BIA
PCRX icon

Biondo Investment Advisors’s Pacira BioSciences PCRX Stock Holding History

Biondo Investment Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,975
Closed -$238K – 84
2020
Q4 		$238K Sell
3,975
-25
-0.6% -$1.46K 0.05% 77
2020
Q3 		$240K Sell
4,000
-1,000
-20% -$58.1K 0.05% 75
2020
Q2 		$262K Buy
+5,000
New +$209K 0.07% 72
2018
Q1 		– Sell
-153,185
Closed -$6.99M – 94
2017
Q4 		$6.99M Sell
153,185
-2,788
-2% -$110K 1.77% 17
2017
Q3 		$5.86M Sell
155,973
-2,230
-1% -$89.7K 1.61% 19
2017
Q2 		$7.55M Sell
158,203
-6,419
-4% -$298K 2.18% 14
2017
Q1 		$5.55M Buy
164,622
+22,149
+16% +$957K 1.98% 13
2016
Q4 		$4.6M Sell
142,473
-20,600
-13% -$687K 1.52% 20
2016
Q3 		$5.58M Sell
163,073
-1,754
-1% -$68.7K 1.89% 15
2016
Q2 		$5.56M Sell
164,827
-15,632
-9% -$768K 1.98% 13
2016
Q1 		$9.56M Sell
180,459
-73,745
-29% -$4.31M 3.62% 8
2015
Q4 		$19.5M Sell
254,204
-2,005
-0.8% -$114K 6.48% 3
2015
Q3 		$10.5M Sell
256,209
-12,852
-5% -$787K 3.5% 8
2015
Q2 		$19M Sell
269,061
-9,891
-4% -$779K 5.71% 5
2015
Q1 		$24.8M Sell
278,952
-3,025
-1% -$307K 7.35% 1
2014
Q4 		$25M Buy
281,977
+2,260
+0.8% +$214K 7.52% 1
2014
Q3 		$27.1M Sell
279,717
-3,056
-1% -$297K 8.33% 1
2014
Q2 		$26M Buy
282,773
+12,937
+5% +$985K 8.19% 1
2014
Q1 		$18.9M Buy
269,836
+1,497
+0.6% +$102K 6.26% 2
2013
Q4 		$15.4M Buy
268,339
+4,899
+2% +$258K 5.27% 5
2013
Q3 		$12.7M Buy
263,440
+85,950
+48% +$3.13M 4.81% 6
2013
Q2 		$5.15M Buy
+177,490
New +$5.13M 2.23% 12

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Biondo Investment Advisors's PCRX Position: Q1 2021 in Review

Biondo Investment Advisors sold out of Pacira BioSciences (PCRX) in Q1 2021, closing a stake of 3,975 shares — an estimated $238K sold.

Biondo Investment Advisors first reported a position in PCRX in Q2 2013 and held it in 22 quarters. The position peaked at $27.1M in Q3 2014. 270 funds tracked by Wall St. Rank hold PCRX as of Q1 2021.

  • Biondo Investment Advisors reported no remaining Pacira BioSciences position as of Q1 2021 after selling out during the quarter.
  • Biondo Investment Advisors sold 3,975 Pacira BioSciences shares in Q1 2021, an estimated $238K.
  • Biondo Investment Advisors first reported a position in Pacira BioSciences in Q2 2013 and held it in 22 quarters.
  • Biondo Investment Advisors's Pacira BioSciences position peaked at $27.1M in Q3 2014.
  • 270 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2021.

Based on Biondo Investment Advisors's 13F filing for Q1 2021, filed 11 May 2021.